Supplement to Rosenwald A, et al. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma. N Engl J Med 2002;346:[removed]SUPPLEMENTARY APPENDIX 1 Statistical Analysis Miss

First Page		Document Content
Date: 2002-06-17 15:19:59 Oncology B-cell chronic lymphocytic leukemia Lymphocytic leukemia Microarrays Major histocompatibility complex International Prognostic Index Gene expression Gene expression profiling in cancer Gene expression profiling Medicine Biology Lymphoma		Supplement to Rosenwald A, et al. The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma. N Engl J Med 2002;346:[removed]SUPPLEMENTARY APPENDIX 1 Statistical Analysis Miss Add to Reading List Source URL: llmpp.nih.gov Download Document from Source Website File Size: 170,42 KB Share Document on Facebook

	Lifebank_Logo_withTag-centered DocID: 1rakV - View Document
	Genome Informatics 15(2): 201–Kernel Mixture Survival Models for Identifying Cancer Subtypes, Predicting Patient’s Cancer Types DocID: 1qki5 - View Document
	Interim statement from the BCSH CLL Guidelines Panel George A Follows1, Adrian Bloor2, Claire Dearden3, Steve Devereux4, Christopher P Fox5, Peter Hillmen6, Ben Kennedy7, Helen McCarthy8, Nilima Parry-Jones9, Piers EM Pa DocID: 1qeKO - View Document
	CURRICULUM VITAE Antje Hoering Cancer Research And Biostatistics (CRAB) Seattle, WAe-mail:  phone: ( DocID: 1q61b - View Document
	PC-691-T100 Monoclonal Antibody to CD5 PerCP (100 tests) Clone: DocID: 1p8uO - View Document